Todd Nichols

Todd Nichols is the SVP of Sales & Marketing at Alkermes. Prior to joining Alkermes, Todd served as the Vice President Sales and Marketing for Inflammation and Immunology at Celgene from January 2018 to December 2019. Todd was responsible for US brand/commercial strategy development, planning and execution for a multi-billion dollar pipeline asset across three therapeutic categories; Multiple Sclerosis, Ulcerative Colitis, and Crohn's Disease. Todd has also held positions as the Vice President Sales and Field Operations for Neurology and Hemophilia at Biogen from January 2014 to December 2017, the Vice President and Head of US Vaccines Business Unit at Merck from January 2009 to December 2014, and Area Vice President of Sales at Schering Pharmaceuticals from January 1995 to December 2009.

Todd Nichols has a Bachelor of Science in Accounting and Business Administration from Elon University's Martha and Spencer Love School of Business.

Todd Nichols reports to Richard F. Pops, CEO & Chairman. They are on a team with Iain Brown - SVP, Finance & Chief Accounting Officer, David J. Gaffin - SVP, Chief Legal Officer, Chief Compliance Officer & Secretary Alkermes plc, and Niels Borgstein - SVP, Late-Stage Clinical Development.